Magnus Group received tremendous applause for the successful completion of the “2nd Edition of International Precision Medicine Conference” (IPMC 2022) which took place on a virtual platform during April 21-23, 2022.

The congress was themed at “One drug doesn’t suit all: Genomic era of precision medicine.”

The two-day summit convened global speakers, healthcare professionals, precision medicine experts, pharma professionals, researchers, scientists and business delegates. Precision medicine has advanced tremendously in the previous decade, and these achievements have made it possible to identify therapy solutions for patients more precisely than ever before. The scientific gathering had expert-led conversations about how to effectively improve precision medicine for all populations. We demonstrated and had brainstorming sessions on cutting-edge technology and workflows for implementing precision medicine in clinical settings, rather than merely in research settings. The colloquium’s proceedings were carried out through a series of invited talks, keynote sessions, Scientific sessions and plenary lectures, and Magnus Group would like to convey its heartfelt gratitude to all of the distinguished keynote speakers and conference goers. We would like to express our heartfelt gratitude to all of the 2nd Edition of International Precision Medicine Conference (IPMC 2022), Guests and Keynote Speakers.

Following the enthusiastic feedback, we are going to organize “3rd Edition of International Precision Medicine Conference” (IPMC 2023) slated during April 24-26, 2023 in Orlando, Florida, USA and virtually. With the theme “Empowering Diagnosis, Treatment and Drugs Through the Lens of Precision Medicine Innovations” we will continue to focus on elevating the patient voice and increasing patient involvement, as we have over the previous many years.